on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group, Inc. Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has filed a Form 8.3 disclosure concerning its interests in Spire Healthcare Group plc's securities. According to the release dated May 18, 2026, Vanguard holds 14,446,326 ordinary shares in Spire, representing a 3.59% stake. This disclosure is in line with Rule 8.3 of the Takeover Code, which mandates disclosure for those possessing 1% or more of relevant securities.
The filing indicates no additional deals aside from the reported holding. On May 15, 2026, Vanguard sold 5,490 ordinary shares at a price of 2.27 GBP each. There are no recent developments in derivatives or options related to this transaction. The announcement confirms there are no agreements or understandings pertaining to indemnity or voting rights.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news